Is CCJ a Buy or a Sell? The Bull and Bear Case (2026)

Last updated July 2026

Short answer

Both cases are real, which is why the question is contested. The bull case for Cameco (CCJ) rests on Nuclear demand and the clean-energy case: Growing interest in nuclear power as a reliable, low-carbon, baseload electricity source, including reactor life extensions, new builds, and datacenter-driven power demand, supports long-term uranium demand. The bear case rests on cameco's results are tied to volatile uranium prices and to global nuclear power sentiment, which can swing on policy and on high-profile events. Analysts covering it publish targets from $84.07 to $169.10 against a $84.69 price, so even the professionals disagree by 65% of their own average. We do not give a verdict. What follows is each case at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.

Cameco (CCJ) is one of the world's largest publicly traded uranium producers and a major supplier of nuclear fuel. Based in Saskatchewan, Canada, it mines uranium from some of the highest-grade deposits in the world, including the Cigar Lake and McArthur River operations, and sells uranium concentrate (U3O8) to utilities that run nuclear power plants. Beyond mining, Cameco participates across the nuclear fuel cycle through refining, conversion, and fuel-fabrication activities, and it holds a significant interest in Westinghouse, a leading provider of nuclear reactor technology and services, acquired alongside Brookfield. Cameco's revenue is tied to long-term contracts with utilities and to uranium spot and contract prices, which are driven by global nuclear power demand, supply discipline, and the broader case for clean, baseload electricity. It trades on the New York Stock Exchange and the Toronto Stock Exchange.

The bull case: what would have to be true for $169.10

The most optimistic published target on CCJ is $169.10, +99.7% from the $84.69 price as of July 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.

1. Nuclear demand and the clean-energy case.

Growing interest in nuclear power as a reliable, low-carbon, baseload electricity source, including reactor life extensions, new builds, and datacenter-driven power demand, supports long-term uranium demand. As one of the largest Western producers, Cameco is positioned to benefit from a structural turn back toward nuclear.

2. Uranium supply discipline and pricing.

Years of underinvestment and mine curtailments tightened uranium supply, and Cameco has managed production to support prices rather than flood the market. Higher contracted and spot uranium prices flow through to revenue and margins, giving the stock direct leverage to the uranium price cycle.

3. Westinghouse and the full fuel cycle.

Cameco's significant interest in Westinghouse, a leading reactor-technology and services provider, plus its refining, conversion, and fuel-fabrication activities, give it exposure across the nuclear fuel cycle beyond mining alone. This broadens its participation in nuclear new-builds and reactor servicing.

The bear case: what would have to be true for $84.07

The most pessimistic published target is $84.07, -0.7% from the current price. That is not a floor and not a forecast; it is roughly what one analyst thinks Cameco is worth if the risks below bite instead of the drivers above.

Cameco's results are tied to volatile uranium prices and to global nuclear power sentiment, which can swing on policy and on high-profile events. Nuclear accidents anywhere can chill demand and pricing for years, as happened after Fukushima. Mining carries operational, geological, and regulatory risk, and major projects can face curtailments or cost overruns. Geopolitics affects uranium supply and trade, including sanctions on Russian nuclear fuel. The Westinghouse stake adds exposure to reactor-project execution and added debt. Verify the latest uranium price, contract book, and production guidance before drawing conclusions.

The bear case deserves the same attention as the bull case, and usually gets less. If you are holding CCJ already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.

Where analysts land on CCJ

12 analysts cover CCJ, with an average target of $131.47 (+55.2% against $84.69) and a split of 21 buy, 4 hold, 0 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the CCJ forecast and price target page.

How is CCJ valued? (as of early 2026)

Price
$84.69
Market cap
$36.89B
P/E (TTM)
79.90
Forward P/E
44.51
Price / book
7.36
Beta
1.00
52-week range
$68.96 to $135.24

Snapshot for CCJ as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.

  • Revenue (TTM): ~$2-3 billion (approximate, verify)
  • Primary product: Uranium concentrate (U3O8)
  • Key assets: Cigar Lake, McArthur River; ~49% Westinghouse stake (verify)
  • P/E (TTM): Elevated and volatile (commodity earnings; approximate, verify)
  • Dividend yield: Small, around or below 1% (approximate, verify)
  • Market cap: ~$25-35 billion (approximate, verify)
  • Listings: NYSE (CCJ) and Toronto Stock Exchange (CCO)

Cameco often trades on a high or volatile price-to-earnings multiple because its earnings swing with uranium prices and reflect the Westinghouse investment. Investors typically value it on the long-term uranium demand and supply outlook and on its contracted sales book rather than on a single year of earnings. All figures are approximate and move with uranium prices and the share price; verify current numbers before relying on them.

How do you decide if CCJ is a buy?

Rather than asking whether CCJ is a buy in the abstract, it tends to help to answer four questions:

  • Thesis: do you believe the bull case above, and is it still true today?
  • Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
  • Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
  • Overlap: check whether you already hold CCJ indirectly through an index or sector ETF before adding more.

What would change your mind on CCJ

Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.

  • Bull case breaks if: Nuclear demand and the clean-energy case stalls in the reported numbers rather than in the narrative around them.
  • Bear case breaks if: cameco's results are tied to volatile uranium prices and to global nuclear power sentiment, which can swing on policy and on high-profile events fails to materialise over several reporting periods while the drivers keep compounding.
  • Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.

For the full picture, see the CCJ stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about CCJ against your real portfolio and see your actual exposure before deciding.

Investing in Cameco with AI

Connect the broker you already use and ask Walnut's AI how CCJ fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.

FAQ

Is CCJ a good stock to buy right now?

+

That depends on which case you find more convincing, and both are on this page. The bull case rests on Nuclear demand and the clean-energy case, with revenue (ttm) at ~$2-3 billion (approximate, verify). The bear case rests on cameco's results are tied to volatile uranium prices and to global nuclear power sentiment, which can swing on policy and on high-profile events. Analysts covering it are spread from $84.07 to $169.10, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Should I sell CCJ?

+

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Cameco's results are tied to volatile uranium prices and to global nuclear power sentiment, which can swing on policy and on high-profile events. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $84.07, -0.7% from the $84.69 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

What is the bull case for CCJ?

+

Nuclear demand and the clean-energy case. Growing interest in nuclear power as a reliable, low-carbon, baseload electricity source, including reactor life extensions, new builds, and datacenter-driven power demand, supports long-term uranium demand. The most optimistic analyst target on CCJ is $169.10, +99.7% from the $84.69 price. That figure is only reachable if this thesis works close to its best case.

What is the bear case for CCJ?

+

Cameco's results are tied to volatile uranium prices and to global nuclear power sentiment, which can swing on policy and on high-profile events. Nuclear accidents anywhere can chill demand and pricing for years, as happened after Fukushima. Mining carries operational, geological, and regulatory risk, and major projects can face curtailments or cost overruns. Geopolitics affects uranium supply and trade, including sanctions on Russian nuclear fuel. The Westinghouse stake adds exposure to reactor-project execution and added debt. Verify the latest uranium price, contract book, and production guidance before drawing conclusions. The most pessimistic published target is $84.07, -0.7% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

What does Cameco do?

+

One of the largest uranium miners and nuclear-fuel suppliers, with a major stake in reactor-technology firm Westinghouse.

What would have to change for CCJ to stop being worth holding?

+

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Nuclear demand and the clean-energy case) stalling in the reported numbers rather than in the narrative, the risk above (cameco's results are tied to volatile uranium prices and to global nuclear power sentiment, which can swing on policy and on high-profile events) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

What is Cameco's (CCJ) ticker symbol?

+

CCJ on the New York Stock Exchange, and CCO on the Toronto Stock Exchange. Officially Cameco Corporation, headquartered in Saskatoon, Saskatchewan, Canada. The NYSE listing lets US investors trade it in dollars during US market hours at major brokerages.

What does Cameco (CCJ) do?

+

Cameco is one of the world's largest uranium miners and nuclear-fuel suppliers. It mines high-grade uranium (notably at Cigar Lake and McArthur River), sells uranium concentrate to nuclear utilities, participates in refining, conversion, and fuel fabrication, and holds a significant stake in reactor-technology company Westinghouse.

Who are Cameco's (CCJ) main competitors?

+

Among uranium producers, primarily Kazatomprom, the large Kazakh producer, plus smaller miners and developers. In the broader fuel cycle and reactor technology, firms like Orano, Urenco, and reactor vendors. For investors, physical-uranium trusts and uranium-mining ETFs compete for capital.

Walnut is informational, not investment advice, and gives no verdict on CCJ. Analyst targets referenced here come from a July 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.

Guides that feature CCJ

CCJ is one of the names covered in these guides. Each one puts the stock next to its peers so you can see where it fits rather than judging it alone.

Related stocks

    Is CCJ a Buy or a Sell? The Bull and Bear Case (2026), Walnut